The study had the main purpose of comparing the desensitizing effect of Nd:YAG laser (1064 nm) and a 15% calcium sodium phosphosilicate paste (CSP-NovaMin) for the treatment of cervical dentin hypersensitivity (CDH) throughout the 6-month follow-up period (TRN #2291636, Sep/2017). In total, 67 patients were selected after a baseline evaluation with a visual analog scale, including middling and severe pain levels, above 4 cm at the scale. Patients were randomly allocated to one of the groups: Nd:YAG laser (100 mJ, 1W, 10 Hz, 83.3 J/cm2) or CSP prophy paste (60-s prophylaxis, rubber cup at low speed). Patients were treated in a single session and pain was assessed immediately, 3 months and 6 months after treatments. When more than one tooth presented CDH, a mean score per patient was considered. Patients were blind to the treatments and pain values, pain evaluator was blind to the treatments and the operator was blind to pain data. Pain relief data and absolute values were analyzed. There was no difference in pain relief between treatments and experimental time-intervals (p > 0.05). Absolute values for pain showed significant reduction in pain immediately after treatments for both groups (p < 0.05). After 6 months, pain level for Nd:YAG laser group continued to decrease (p < 0.05) while for CSP group this did not change (p > 0.05). For both groups, pain was lower than at baseline after 6 months. Both treatments were efficient in reducing CDH over 6 months and Nd:YAG laser group showed the lowest pain levels. Nd:YAG laser and CSP prophy paste should be considered efficient treatments for CDH with positive immediate and long-term effects.
{"title":"Effect of 1064 nm Nd:YAG laser or 15% calcium sodium phosphosilicate prophy paste on dentin hypersensitivity over six months: a double-blind randomized clinical trial.","authors":"Vinicius Maximiano, Mirian Lumi Yoshida, Claudio Mendes Pannuti, Ana Cecilia Corrêa Aranha","doi":"10.1007/s10103-024-04223-8","DOIUrl":"10.1007/s10103-024-04223-8","url":null,"abstract":"<p><p>The study had the main purpose of comparing the desensitizing effect of Nd:YAG laser (1064 nm) and a 15% calcium sodium phosphosilicate paste (CSP-NovaMin) for the treatment of cervical dentin hypersensitivity (CDH) throughout the 6-month follow-up period (TRN #2291636, Sep/2017). In total, 67 patients were selected after a baseline evaluation with a visual analog scale, including middling and severe pain levels, above 4 cm at the scale. Patients were randomly allocated to one of the groups: Nd:YAG laser (100 mJ, 1W, 10 Hz, 83.3 J/cm<sup>2</sup>) or CSP prophy paste (60-s prophylaxis, rubber cup at low speed). Patients were treated in a single session and pain was assessed immediately, 3 months and 6 months after treatments. When more than one tooth presented CDH, a mean score per patient was considered. Patients were blind to the treatments and pain values, pain evaluator was blind to the treatments and the operator was blind to pain data. Pain relief data and absolute values were analyzed. There was no difference in pain relief between treatments and experimental time-intervals (p > 0.05). Absolute values for pain showed significant reduction in pain immediately after treatments for both groups (p < 0.05). After 6 months, pain level for Nd:YAG laser group continued to decrease (p < 0.05) while for CSP group this did not change (p > 0.05). For both groups, pain was lower than at baseline after 6 months. Both treatments were efficient in reducing CDH over 6 months and Nd:YAG laser group showed the lowest pain levels. Nd:YAG laser and CSP prophy paste should be considered efficient treatments for CDH with positive immediate and long-term effects.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"515"},"PeriodicalIF":2.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145715049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.1007/s10103-025-04763-7
Zhantang Yuan, Zhihui Xu, Xia Wan, Tonghan Zhang
To evaluate whether Er: YAG surgery and Nd: YAG-based low-level laser therapy (LLLT), combined with medical collagen, improve early postoperative outcomes after extraction of impacted mandibular third molars. Adults undergoing surgical removal of mesioangular or horizontal impacted mandibular third molars were randomized equally (1:1:1:1) to blank control (BCG), collagen only (COL), lasers only (LAS), or collagen plus lasers (COL + LAS). Primary endpoints were pain (VAS; spontaneous and swallowing; POD1/3/7), swelling (POD1/3/7), trismus (POD1/3/7), and early mucosal healing (POD3/7). Secondary endpoints were bleeding (30 min post-extraction only), cutaneous induration/ecchymosis (POD7), alveolar osteitis (POD3/7), and local cytokines (IL-1β, IL-6, TNF-α; POD3/7). In 120 patients, COL + LAS was superior: less pain, swelling, and trismus at POD1/3 and higher early mucosal-healing rates at POD3/7 than BCG, COL, or LAS; by POD7, between-group differences in pain, swelling, and trismus were minimal. All active arms reduced 30-min bleeding versus BCG. At POD7, cutaneous induration was lowest with COL + LAS (ecchymosis not significant). Cytokines declined overall; IL-1β and TNF-α were lowest with COL + LAS at POD3/7, whereas IL-6 decreased similarly across active arms. Er: YAG surgery plus Nd: YAG-based LLLT with medical collagen improved short-term recovery after impacted mandibular third-molar surgery.
{"title":"Er:YAG and Nd:YAG-based low-level laser therapy (LLLT) with medical collagen improve third-molar extraction wound healing: a randomized controlled trial.","authors":"Zhantang Yuan, Zhihui Xu, Xia Wan, Tonghan Zhang","doi":"10.1007/s10103-025-04763-7","DOIUrl":"10.1007/s10103-025-04763-7","url":null,"abstract":"<p><p>To evaluate whether Er: YAG surgery and Nd: YAG-based low-level laser therapy (LLLT), combined with medical collagen, improve early postoperative outcomes after extraction of impacted mandibular third molars. Adults undergoing surgical removal of mesioangular or horizontal impacted mandibular third molars were randomized equally (1:1:1:1) to blank control (BCG), collagen only (COL), lasers only (LAS), or collagen plus lasers (COL + LAS). Primary endpoints were pain (VAS; spontaneous and swallowing; POD1/3/7), swelling (POD1/3/7), trismus (POD1/3/7), and early mucosal healing (POD3/7). Secondary endpoints were bleeding (30 min post-extraction only), cutaneous induration/ecchymosis (POD7), alveolar osteitis (POD3/7), and local cytokines (IL-1β, IL-6, TNF-α; POD3/7). In 120 patients, COL + LAS was superior: less pain, swelling, and trismus at POD1/3 and higher early mucosal-healing rates at POD3/7 than BCG, COL, or LAS; by POD7, between-group differences in pain, swelling, and trismus were minimal. All active arms reduced 30-min bleeding versus BCG. At POD7, cutaneous induration was lowest with COL + LAS (ecchymosis not significant). Cytokines declined overall; IL-1β and TNF-α were lowest with COL + LAS at POD3/7, whereas IL-6 decreased similarly across active arms. Er: YAG surgery plus Nd: YAG-based LLLT with medical collagen improved short-term recovery after impacted mandibular third-molar surgery.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"512"},"PeriodicalIF":2.4,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12682916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145701362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.1007/s10103-025-04773-5
Huihui Tuo, Hengtong Fan, Yan Sun, Yajie Yang, Manyu Ju, Yuhan Xie, Yuqian Wang, Dalin He, Yan Zheng
This self-controlled prospective study evaluated the efficacy and safety of 450 nm blue laser-mediated aminolevulinic acid photodynamic therapy (ALA-BL-PDT) in 28 patients with plaque psoriasis. Participants received four treatment sessions at two-week intervals. At two weeks post-treatment, 67.9% (19/28) achieved Physician Global Assessment (PGA) scores of 0 or 1 (clear or almost clear). Treatment response correlated significantly with baseline disease severity, with higher efficacy observed in patients with body surface area (BSA) ≤ 5% (84.2%) and Psoriasis Area and Severity Index (PASI) ≤ 5 (86.7%) (both p < 0.05). Treatment-associated pain was well-tolerated and decreased significantly after the first session. The one-year recurrence rate among responders was 47.4% (9/19). These preliminary results suggest ALA-BL-PDT may be effective and well-tolerated treatment for mild-to-moderate plaque psoriasis, though larger randomized controlled trials are needed for validation.
{"title":"Efficacy of 450-nm blue laser-mediated aminolevulinic acid photodynamic therapy for plaque psoriasis: a prospective self-controlled clinical trial.","authors":"Huihui Tuo, Hengtong Fan, Yan Sun, Yajie Yang, Manyu Ju, Yuhan Xie, Yuqian Wang, Dalin He, Yan Zheng","doi":"10.1007/s10103-025-04773-5","DOIUrl":"10.1007/s10103-025-04773-5","url":null,"abstract":"<p><p>This self-controlled prospective study evaluated the efficacy and safety of 450 nm blue laser-mediated aminolevulinic acid photodynamic therapy (ALA-BL-PDT) in 28 patients with plaque psoriasis. Participants received four treatment sessions at two-week intervals. At two weeks post-treatment, 67.9% (19/28) achieved Physician Global Assessment (PGA) scores of 0 or 1 (clear or almost clear). Treatment response correlated significantly with baseline disease severity, with higher efficacy observed in patients with body surface area (BSA) ≤ 5% (84.2%) and Psoriasis Area and Severity Index (PASI) ≤ 5 (86.7%) (both p < 0.05). Treatment-associated pain was well-tolerated and decreased significantly after the first session. The one-year recurrence rate among responders was 47.4% (9/19). These preliminary results suggest ALA-BL-PDT may be effective and well-tolerated treatment for mild-to-moderate plaque psoriasis, though larger randomized controlled trials are needed for validation.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"513"},"PeriodicalIF":2.4,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145701357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to investigate the effects of diode laser parameters on the thermal response and surface morphology of RBM (Resorbable Blast Media), SLA (Sandblasted, Large-grit, Acid-etched), and additively manufactured Ti6Al4V titanium surfaces, and to determine whether surface type influences heat distribution and integrity, which is clinically relevant in peri-implantitis treatment. A total of 144 titanium discs with three different surface treatments (RBM, SLA, and additively manufactured Ti6Al4V as the control group) were irradiated with a 940 nm diode laser at varying power levels (1 W, 2 W, 3 W), durations (30 s, 60 s), and modes (continuous, pulsed). Surface temperatures were recorded using thermal imaging. Morphological and elemental changes were evaluated via Scanning Electron Microscopy (SEM) and Energy-Dispersive X-ray Spectroscopy (EDS) analyses. A four-way Aligned Rank Transform Analysis of Variance (ART ANOVA) was used to analyze the effects of variables. Temperature increases were significantly influenced by all tested variables (p < 0.001). The RBM group exhibited the highest peak temperature (185 °C at 3 W pulsed mode, 60 s), while SLA surfaces consistently showed the lowest (39.9 °C at 1 W continius mode, 30 s). Pulsed mode and longer exposure times produced higher temperatures, except at 1 W, which resulted in the lowest temperature rise regardless of surface treatment. SEM images revealed mild surface alterations at higher power, with RBM exhibiting localized depressions and SLA displaying minor fragmentation of surface textures. EDS analysis indicated no major changes in elemental composition post-irradiation. The study highlights that different titanium surface types respond distinctly to diode laser irradiation, with RBM surfaces being more thermally reactive. Uniform laser protocols may not be appropriate for all implant surfaces. Careful consideration of power, duration, and surface characteristics is essential to avoid potential thermal damage during peri-implantitis treatment.
{"title":"Effects of diode laser parameters on thermal response of RBM, SLA, and additively manufactured titanium surfaces.","authors":"Ozlem Sarac Atagun, Ülkü Tuğba Kalyoncuoğlu, Bengi Yilmaz Erdemli, Simel Ayyildiz","doi":"10.1007/s10103-025-04759-3","DOIUrl":"10.1007/s10103-025-04759-3","url":null,"abstract":"<p><p>This study aimed to investigate the effects of diode laser parameters on the thermal response and surface morphology of RBM (Resorbable Blast Media), SLA (Sandblasted, Large-grit, Acid-etched), and additively manufactured Ti6Al4V titanium surfaces, and to determine whether surface type influences heat distribution and integrity, which is clinically relevant in peri-implantitis treatment. A total of 144 titanium discs with three different surface treatments (RBM, SLA, and additively manufactured Ti6Al4V as the control group) were irradiated with a 940 nm diode laser at varying power levels (1 W, 2 W, 3 W), durations (30 s, 60 s), and modes (continuous, pulsed). Surface temperatures were recorded using thermal imaging. Morphological and elemental changes were evaluated via Scanning Electron Microscopy (SEM) and Energy-Dispersive X-ray Spectroscopy (EDS) analyses. A four-way Aligned Rank Transform Analysis of Variance (ART ANOVA) was used to analyze the effects of variables. Temperature increases were significantly influenced by all tested variables (p < 0.001). The RBM group exhibited the highest peak temperature (185 °C at 3 W pulsed mode, 60 s), while SLA surfaces consistently showed the lowest (39.9 °C at 1 W continius mode, 30 s). Pulsed mode and longer exposure times produced higher temperatures, except at 1 W, which resulted in the lowest temperature rise regardless of surface treatment. SEM images revealed mild surface alterations at higher power, with RBM exhibiting localized depressions and SLA displaying minor fragmentation of surface textures. EDS analysis indicated no major changes in elemental composition post-irradiation. The study highlights that different titanium surface types respond distinctly to diode laser irradiation, with RBM surfaces being more thermally reactive. Uniform laser protocols may not be appropriate for all implant surfaces. Careful consideration of power, duration, and surface characteristics is essential to avoid potential thermal damage during peri-implantitis treatment.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"511"},"PeriodicalIF":2.4,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to evaluate the efficacy of low-level laser application in the treatment of periodontal intra-bony defects. Two independent reviewers conducted searches for articles published in English. The primary objective was to investigate whether clinical parameters improved in periodontal regeneration therapy with and without low-level laser therapy (LLLT). The primary outcome was probing depth (PD), while the secondary outcome measures were clinical attachment level (CAL), gingival recession (GR), and bone defect depth. After screening and eligibility assessment, eight studies were included in the analysis. For the primary outcome measure (PD), after sensitivity analysis, the reduction in PD from baseline to 3 months was greater in the laser group than in the non-laser group (P = 0.02). For the secondary outcome measure (CAL), after sensitivity analysis, the increase in CAL from baseline to 3 months was greater in the laser group (P < 0.001). Although laser therapy may be beneficial for early wound healing, the current evidence does not support its routine use in periodontal regenerative surgery. Further high-quality studies are warranted to evaluate its clinical efficacy.
{"title":"The application of low-level laser in the treatment of periodontal Intra-bony defects: systematic review and meta-analysis.","authors":"Yiru Wei, Ruonan Xu, Aishan Yilihamu, Yuting Chen, Gulinuer Awuti","doi":"10.1007/s10103-025-04767-3","DOIUrl":"10.1007/s10103-025-04767-3","url":null,"abstract":"<p><p>This study aimed to evaluate the efficacy of low-level laser application in the treatment of periodontal intra-bony defects. Two independent reviewers conducted searches for articles published in English. The primary objective was to investigate whether clinical parameters improved in periodontal regeneration therapy with and without low-level laser therapy (LLLT). The primary outcome was probing depth (PD), while the secondary outcome measures were clinical attachment level (CAL), gingival recession (GR), and bone defect depth. After screening and eligibility assessment, eight studies were included in the analysis. For the primary outcome measure (PD), after sensitivity analysis, the reduction in PD from baseline to 3 months was greater in the laser group than in the non-laser group (P = 0.02). For the secondary outcome measure (CAL), after sensitivity analysis, the increase in CAL from baseline to 3 months was greater in the laser group (P < 0.001). Although laser therapy may be beneficial for early wound healing, the current evidence does not support its routine use in periodontal regenerative surgery. Further high-quality studies are warranted to evaluate its clinical efficacy.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"510"},"PeriodicalIF":2.4,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12675631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To evaluate the clinical utility of endoscopic laser speckle contrast imaging (eLSCI) for intraoperative assessment of parathyroid gland (PTG) perfusion and functional preservation.
Methods: Fifteen patients undergoing unilateral/bilateral thyroidectomy at The Affiliated Lihuili Hospital of Ningbo University (November 2024 to April 2025) were prospectively enrolled. PTG perfusion was quantified using eLSCI by recording blood flow index (BFI) before and after thyroid resection. Serum parathyroid hormone (PTH) and calcium levels were measured preoperatively, at 15-min post-resection, and 24-h postoperatively. Pearson correlation analysis was used to assess the linear association between perfusion and functional parameters, while Spearman's rank correlation test was concurrently performed to verify the robustness.
Results: A significant correlation existed between the BFI change ratio and PTH change ratio at 15-min post-resection (r = 0.672, p = 0.006) and 24-h postoperatively (r = 0.671, p = 0.006). No significant correlation was observed between BFI change ratio and serum calcium change ratio at either timepoint (p > 0.05).
Conclusion: The eLSCI system enables real-time quantitative assessment of intraoperative parathyroid perfusion and demonstrates feasibility in predicting postoperative parathyroid function, holding significant potential for clinical application.
目的:探讨内镜下激光散斑造影(eLSCI)术中评估甲状旁腺(PTG)灌注及功能保存的临床应用价值。方法:前瞻性入选宁波大学附属丽丽丽医院于2024年11月至2025年4月行单侧/双侧甲状腺切除术的患者15例。采用eLSCI记录甲状腺切除术前后血流量指数(BFI),定量PTG灌注。术前、术后15分钟和术后24小时分别测定血清甲状旁腺激素(PTH)和钙水平。采用Pearson相关分析评估灌注与功能参数的线性相关性,同时采用Spearman秩相关检验验证稳健性。结果:术后15 min (r = 0.672, p = 0.006)和术后24 h (r = 0.671, p = 0.006) BFI变化率与PTH变化率存在显著相关性。各时间点BFI变化率与血钙变化率无显著相关性(p < 0.05)。结论:eLSCI系统能够实时定量评估术中甲状旁腺灌注,预测术后甲状旁腺功能具有可行性,具有重要的临床应用潜力。
{"title":"Endoscopic laser speckle imaging enables real-time prediction of parathyroid function in thyroidectomy.","authors":"Yingying Cui, Mengsha Zou, Baoan Song, Jiawei Tang, Jianan Zhang, Shang Shi, Gaoxiang Chen","doi":"10.1007/s10103-025-04760-w","DOIUrl":"10.1007/s10103-025-04760-w","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the clinical utility of endoscopic laser speckle contrast imaging (eLSCI) for intraoperative assessment of parathyroid gland (PTG) perfusion and functional preservation.</p><p><strong>Methods: </strong>Fifteen patients undergoing unilateral/bilateral thyroidectomy at The Affiliated Lihuili Hospital of Ningbo University (November 2024 to April 2025) were prospectively enrolled. PTG perfusion was quantified using eLSCI by recording blood flow index (BFI) before and after thyroid resection. Serum parathyroid hormone (PTH) and calcium levels were measured preoperatively, at 15-min post-resection, and 24-h postoperatively. Pearson correlation analysis was used to assess the linear association between perfusion and functional parameters, while Spearman's rank correlation test was concurrently performed to verify the robustness.</p><p><strong>Results: </strong>A significant correlation existed between the BFI change ratio and PTH change ratio at 15-min post-resection (r = 0.672, p = 0.006) and 24-h postoperatively (r = 0.671, p = 0.006). No significant correlation was observed between BFI change ratio and serum calcium change ratio at either timepoint (p > 0.05).</p><p><strong>Conclusion: </strong>The eLSCI system enables real-time quantitative assessment of intraoperative parathyroid perfusion and demonstrates feasibility in predicting postoperative parathyroid function, holding significant potential for clinical application.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"508"},"PeriodicalIF":2.4,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12672801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145661449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gingival pigmentation is a common cosmetic concern that can negatively impact a patient's smile aesthetics. Laser-assisted depigmentation has emerged as a reliable and effective treatment modality. The study aimed to compare the efficacy, comfortability of the patient, and the post-operative outcomes among patients who underwent either an ablative or a non-ablative diode 450 nm laser for gingival depigmentation. A split-mouth, single-blind, randomized controlled trial was conducted on 20 subjects exhibiting physiological pigmentation scores of 2 or more, as assessed by the Dummett index. A diode laser emitting 450 nm wavelength was employed. One side of each subject's mouth was randomly assigned to receive ablative laser treatment, while the contralateral side received non-ablative treatment. Primary outcome measures included changes in Oral Pigmentation Index and Melanin Pigmentation Index scores at baseline and at 1, 6, and 12 months' post-treatment. Patient perception of pain and discomfort was assessed using a modified McGill Pain Questionnaire. Both ablative and non-ablative techniques demonstrated significant reductions in OPI and MPI scores at all follow-up time points. Immediate and total depigmentation was achieved using ablative techniques, which showed fewer rates of re-pigmentation but higher intraoperative discomfort. In contrast, non-ablative techniques result in less pain but required more sessions to obtain optimal results. The choice of technique should be individualized based on patient preferences and clinician expertise. Non-ablative treatment may be preferred for patients seeking minimal discomfort and rapid healing, while ablative treatment may be suitable for patients who prioritize complete pigment removal in one session.
{"title":"\"Laser assisted gingival melanin depigmentation using diode 450 nm; ablative vs. non-ablative techniques: randomized clinical trial\".","authors":"Walid Altayeb, Kenneth Luk, Josep Arnabat-Dominguez, Ahmed Abdullah, Raneem Darkazali, Omar Hamadah","doi":"10.1007/s10103-025-04762-8","DOIUrl":"10.1007/s10103-025-04762-8","url":null,"abstract":"<p><p>Gingival pigmentation is a common cosmetic concern that can negatively impact a patient's smile aesthetics. Laser-assisted depigmentation has emerged as a reliable and effective treatment modality. The study aimed to compare the efficacy, comfortability of the patient, and the post-operative outcomes among patients who underwent either an ablative or a non-ablative diode 450 nm laser for gingival depigmentation. A split-mouth, single-blind, randomized controlled trial was conducted on 20 subjects exhibiting physiological pigmentation scores of 2 or more, as assessed by the Dummett index. A diode laser emitting 450 nm wavelength was employed. One side of each subject's mouth was randomly assigned to receive ablative laser treatment, while the contralateral side received non-ablative treatment. Primary outcome measures included changes in Oral Pigmentation Index and Melanin Pigmentation Index scores at baseline and at 1, 6, and 12 months' post-treatment. Patient perception of pain and discomfort was assessed using a modified McGill Pain Questionnaire. Both ablative and non-ablative techniques demonstrated significant reductions in OPI and MPI scores at all follow-up time points. Immediate and total depigmentation was achieved using ablative techniques, which showed fewer rates of re-pigmentation but higher intraoperative discomfort. In contrast, non-ablative techniques result in less pain but required more sessions to obtain optimal results. The choice of technique should be individualized based on patient preferences and clinician expertise. Non-ablative treatment may be preferred for patients seeking minimal discomfort and rapid healing, while ablative treatment may be suitable for patients who prioritize complete pigment removal in one session.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"509"},"PeriodicalIF":2.4,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1007/s10103-025-04757-5
Poornima Chittabathina, Sruthima Nvs Gottumukkala, Gautami S Penmetsa, Ksv Ramesh, P Mohan Kumar, K Anil Kumar, M Gokul Nishanth
{"title":"Correction to: Clinical and microbiological outcomes of adjunctive photobiomodulation using various wavelengths in treatment of intrabony defects: a randomized controlled clinical trial.","authors":"Poornima Chittabathina, Sruthima Nvs Gottumukkala, Gautami S Penmetsa, Ksv Ramesh, P Mohan Kumar, K Anil Kumar, M Gokul Nishanth","doi":"10.1007/s10103-025-04757-5","DOIUrl":"10.1007/s10103-025-04757-5","url":null,"abstract":"","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"505"},"PeriodicalIF":2.4,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1007/s10103-025-04758-4
Cristina Paixão Durães, Larissa Lopes Fonseca, Lorena Dos Reis Pereira Queiroz, Ricardo Santiago Gomez, Victor Hugo Dantas Guimarães, Sérgio Henrique Sousa Santos, Alfredo Maurício Batista de Paula, Lucyana Conceição Farias, André Luiz Sena Guimarães
{"title":"Photobiomodulation enhances radiosensitivity and suppresses oral squamous cell carcinoma in a 4NQO-induced mouse model.","authors":"Cristina Paixão Durães, Larissa Lopes Fonseca, Lorena Dos Reis Pereira Queiroz, Ricardo Santiago Gomez, Victor Hugo Dantas Guimarães, Sérgio Henrique Sousa Santos, Alfredo Maurício Batista de Paula, Lucyana Conceição Farias, André Luiz Sena Guimarães","doi":"10.1007/s10103-025-04758-4","DOIUrl":"10.1007/s10103-025-04758-4","url":null,"abstract":"","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"507"},"PeriodicalIF":2.4,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1007/s10103-025-04750-y
Ghufran Abo Zaken, Marah Mhna Moussa, Muhammad Talaat Muhammad Nudar Albeik, Abdullah Omar, Samir Almahfoud
<p><p>Surgical excision remains the cornerstone treatment for skin cancer, considered the gold standard in clinical practice. However, alternative methods such as laser therapy are being explored for their potential to achieve tumor control while minimizing tissue damage and improving cosmetic outcomes. This review analyzes the existing literature on the use of Nd: YAG laser in the management of non-melanoma and melanoma skin cancer, with the aim of evaluating clearance and recurrence rates, as well as gaining deeper insights into the efficacy, safety, and potential side effects linked to this treatment approach. A systematic literature search was conducted using Embase, PubMed, Google Scholar, and Cochrane with the keywords: "Nd: YAG laser," "skin cancer," and "treatment." The search encompassed studies published from 1985 to July 2023 and included prospective, retrospective, double-blind randomized controlled trials, and non-blinded clinical trials in English. Studies were selected based on their focus on the use of Nd: YAG laser for non-melanoma including basal cell carcinoma and squamous cell carcinoma and melanoma skin cancer treatment, specifically excluding those that investigated the combination of ND: YAG laser with other therapies. Only studies reporting on the direct application of ND: YAG laser in treating various forms of skin cancer or premalignant skin lesions were considered for inclusion. Across all identified Nd: YAG laser studies from 1985 to 2023 (n = 12), a total of 7,358 histologically confirmed skin malignancies were reported, including 6,846 basal cell carcinomas (BCCs), 185 squamous cell carcinomas (SCCs), 323 malignant melanomas, and 4 cases of Bowen's disease. BCCs accounted for the vast majority of treated lesions (93.0%), followed by malignant melanoma (4.4%), SCC (2.5%), and Bowen's disease (0.05%). In calculating these totals, only lesions explicitly reported in each study were included. For instance, Brunner et al. (1985) described four patients with nevoid basal cell carcinoma syndrome as having "hundreds" of lesions; however, because the exact number was not provided, only the 200 histologically confirmed BCCs from this cohort were counted to avoid overestimation. No overlapping patients between studies were assumed unless explicitly noted. Moskalik et al. (2009) treated 188 recurrent limited BCCs alongside 3,346 primary BCCs, while Moskalik and Kozlow (2010) treated 172 recurrent limited BCCs within a cohort of 2,837 patients. El Tonsy et al. (2004) included patients with previously treated lesions, emphasizing the clearance of 37 BCCs, some of which were recurrent. Sharmazan et al. (1996) and later studies (Ortiz 2015/2018; Ahluwalia 2019; Markowitz & Bressler 2021; Kranz 2023) mostly treated primary BCCs but some non-facial and challenging anatomical locations likely included previously treated lesions. SCCs and melanomas were treated less frequently, usually in early-stage or thin lesions, and Bowen's disease
{"title":"Nd: YAG laser in the treatment of non-melanoma and melanoma skin cancers.","authors":"Ghufran Abo Zaken, Marah Mhna Moussa, Muhammad Talaat Muhammad Nudar Albeik, Abdullah Omar, Samir Almahfoud","doi":"10.1007/s10103-025-04750-y","DOIUrl":"10.1007/s10103-025-04750-y","url":null,"abstract":"<p><p>Surgical excision remains the cornerstone treatment for skin cancer, considered the gold standard in clinical practice. However, alternative methods such as laser therapy are being explored for their potential to achieve tumor control while minimizing tissue damage and improving cosmetic outcomes. This review analyzes the existing literature on the use of Nd: YAG laser in the management of non-melanoma and melanoma skin cancer, with the aim of evaluating clearance and recurrence rates, as well as gaining deeper insights into the efficacy, safety, and potential side effects linked to this treatment approach. A systematic literature search was conducted using Embase, PubMed, Google Scholar, and Cochrane with the keywords: \"Nd: YAG laser,\" \"skin cancer,\" and \"treatment.\" The search encompassed studies published from 1985 to July 2023 and included prospective, retrospective, double-blind randomized controlled trials, and non-blinded clinical trials in English. Studies were selected based on their focus on the use of Nd: YAG laser for non-melanoma including basal cell carcinoma and squamous cell carcinoma and melanoma skin cancer treatment, specifically excluding those that investigated the combination of ND: YAG laser with other therapies. Only studies reporting on the direct application of ND: YAG laser in treating various forms of skin cancer or premalignant skin lesions were considered for inclusion. Across all identified Nd: YAG laser studies from 1985 to 2023 (n = 12), a total of 7,358 histologically confirmed skin malignancies were reported, including 6,846 basal cell carcinomas (BCCs), 185 squamous cell carcinomas (SCCs), 323 malignant melanomas, and 4 cases of Bowen's disease. BCCs accounted for the vast majority of treated lesions (93.0%), followed by malignant melanoma (4.4%), SCC (2.5%), and Bowen's disease (0.05%). In calculating these totals, only lesions explicitly reported in each study were included. For instance, Brunner et al. (1985) described four patients with nevoid basal cell carcinoma syndrome as having \"hundreds\" of lesions; however, because the exact number was not provided, only the 200 histologically confirmed BCCs from this cohort were counted to avoid overestimation. No overlapping patients between studies were assumed unless explicitly noted. Moskalik et al. (2009) treated 188 recurrent limited BCCs alongside 3,346 primary BCCs, while Moskalik and Kozlow (2010) treated 172 recurrent limited BCCs within a cohort of 2,837 patients. El Tonsy et al. (2004) included patients with previously treated lesions, emphasizing the clearance of 37 BCCs, some of which were recurrent. Sharmazan et al. (1996) and later studies (Ortiz 2015/2018; Ahluwalia 2019; Markowitz & Bressler 2021; Kranz 2023) mostly treated primary BCCs but some non-facial and challenging anatomical locations likely included previously treated lesions. SCCs and melanomas were treated less frequently, usually in early-stage or thin lesions, and Bowen's disease","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"506"},"PeriodicalIF":2.4,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}